IP Library › Granted Patent US 11,437,141
Granted Patent B2
US 11,437,141 · App. 15/422,196 · Granted Sep 6, 2022

Performance reports associated with continuous sensor data from multiple analysis time periods

Inventors: Michael Robert Mensinger (San Diego, CA); Deborah M. Ruppert (San Diego, CA)
Assignee: Dexcom, Inc.
G16H50/20A61B5/0031A61B5/14503A61B5/14532A61B5/14546A61B5/486A61B5/681A61B5/7275A61B5/743G16H15/00A61B2560/045
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,437,141
App. No.
15/422,196
Filed
Feb 1, 2017
Granted
Sep 6, 2022
Kind
B2
Art Unit
1631
USPC
702/19
Abstract

A method of providing performance reports to persons associated with the monitoring of an analyte level, such as blood glucose concentrations in a host, is provided. The performance reports can indicate a measure of an analyte variability of the host over a first analysis time period compared to a measure of analyte variability of the host over one or more other analysis time periods. The analyte level of the host can be received in each of a plurality of sensor readings from a continuous analyte sensor, such as multiple sensor readings per hour, so that the analyte variability that is used in determining the performance report of the host can be based on not just a few metered readings taken by the host, but a plurality of intermittent readings that are taken by a continuous analyte sensor, for example. Various types of performance reports can be generated, such as reports that comprise charts, graphs, tables, and/or other visual indicia of a host's performance during one analysis period versus another analysis period.

Claims (20)

1. A method of analyzing continuous analyte sensor data associated with a host, wherein the continuous analyte sensor data is representative of glucose levels of the host, the method comprising:

providing, on a user interface, one or more user interface features for a first analysis time period and a second analysis time period to be selected through user interaction with the one or more user interface features;

receiving, through the user interface, a user selection indicative of the first analysis time period and the second analysis time period, in response to the user interaction with the one or more user interface features, wherein the first analysis time period and the second analysis time period are nonconsecutive time periods;

based on the user selection, accessing a first plurality of blood glucose readings associated with the host for the first analysis time period, wherein each of the first plurality of blood glucose readings is indicative of a blood glucose level of the host at a respective time during the first analysis time period;

based on the user selection, accessing a second plurality of blood glucose readings associated with the host for the second analysis time period, wherein each of the second plurality of blood glucose readings is indicative of a blood glucose level of the host at a respective time during the second analysis time period;

determining a glucose variability metric for each of the first and the second analysis time periods, the glucose variability metric indicating a level of glucose variability in the respective plurality of blood glucose readings for the respective analysis time period;

comparing the glucose variability metrics of the first and the second analysis time periods;

determining whether levels of glucose variability are improving over time between the first and the second analysis time periods based on the comparing; and

generating a performance report indicating a relationship between the first plurality of blood glucose readings and the second plurality of blood glucose readings, wherein the performance report includes a first non-numerical performance indicator when the levels of glucose variability indicate an improvement between the first and the second analysis time periods, and a second non-numerical performance indicator when the levels of glucose variability indicate a lack of improvement between the first and the second analysis time periods.

2. The method of claim 1 , wherein the performance report further indicates a relationship between the first and the second plurality of blood glucose readings and target sensor data.

3. The method of claim 2 , wherein the target sensor data comprises target glucose values determined based on a performance goal for the host.

4. The method of claim 1 , further comprising:

initiating transmission of clinical feedback to the host in response to determining that the relationship between the first and the second plurality of blood glucose readings meets criteria indicative of providing the host with clinical feedback.

5. The method of claim 1 , wherein the first and the second plurality of blood glucose readings comprise more than 72 blood glucose readings for each 24 hour period of an at least one week period.

6. The method of claim 1 , further comprising transmitting the performance report to a caretaker computing device.

7. The method of claim 1 , wherein the nonconsecutive time periods are nonconsecutive quarters of a year.

8. The method of claim 1 , wherein the glucose variability metric of the respective analysis time period comprises one or more of a mean glucose level, a standard deviation of blood glucose readings during the respective analysis time period, a trend during the respective analysis time period, a percentage and/or quantity of days within the respective time period in which the host used the continuous analyte sensor for a minimum time, or combinations thereof.

9. The method of claim 1 , wherein the first non-numerical performance indicator is a positive graphic, and the second non-numerical performance indicator is a negative graphic.

10. The method of claim 1 , wherein the performance report further comprises a third non-numerical performance indicator when the levels of glucose variability are substantially unchanged.

11. The method of claim 10 , wherein the third non-numerical performance indicator is a neutral graphic.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 3, 2017
From: MENSINGER, MICHAEL R.; RUPPERT, DEBORAH M.
To: DEXCOM, INC.
Reel/Frame 041166/0898 →
Continuity (3)
Continuation 12770618 · Apr 29, 2010
Provisional Application 61174436 · Apr 30, 2009
Related Publication 20170143251A1 · May 25, 2017
Cited By (4)
US 1,068,516 US 1,083,640 US 1,083,977 US 1,137,686